Eric Mortensen

Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts

Surya P. Bhatt, Klaus F. Rabe, Nicola A. Hanania et al. · New England Journal of Medicine · 2023 · 407 citations · Full text

Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial

Christopher J. Hawkey, Loren Laine, Thomas Simon et al. · Arthritis & Rheumatism · 2000 · 365 citations

Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain

Lynn R. Webster, Jan Peter Jansen, John F. Peppin et al. · Pain · 2008 · 144 citations

Dose-finding Study, Opioid Epidemic, Spontaneous Bowel Movements +22

Clinical trial: alvimopan for the management of post‐operative ileus after abdominal surgery: results of an international randomized, double‐blind, multicentre, placebo‐controlled clinical study

Markus W. Büchler, Carola Seiler, J. R. T. Monson et al. · Alimentary Pharmacology & Therapeutics · 2008 · 141 citations · Full text

ZBP-89, a Krüppel-Like Zinc Finger Protein, Inhibits Epidermal Growth Factor Induction of the Gastrin Promoter

Juanita L. Merchant, Gaitry R. Iyer, Brigit R. Taylor et al. · Molecular and Cellular Biology · 1996 · 134 citations · Full text